SKBA Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.4M | Hold |
32,360
| – | – | 1.56% | 33 |
|
|
2025
Q4 | $10.6M | Sell |
32,360
-2,300
| -7% | -$730K | 1.5% | 35 |
|
|
2025
Q3 | $9.78M | Hold |
34,660
| – | – | 1.35% | 38 |
|
|
2025
Q2 | $9.68M | Buy |
34,660
+100
| +0.3% | +$28.3K | 1.39% | 40 |
|
|
2025
Q1 | $10.8M | Buy |
34,560
+10,400
| +43% | +$3.07M | 1.6% | 26 |
|
|
2024
Q4 | $6.3M | Buy |
24,160
+3,600
| +18% | +$1.07M | 1% | 51 |
|
|
2024
Q3 | $6.62M | Sell |
20,560
-550
| -3% | -$180K | 0.98% | 51 |
|
|
2024
Q2 | $6.6M | Sell |
21,110
-296
| -1% | -$87K | 1.06% | 45 |
|
|
2024
Q1 | $6.09M | Sell |
21,406
-255
| -1% | -$74.6K | 0.95% | 49 |
|
|
2023
Q4 | $6.24M | Sell |
21,661
-19,600
| -48% | -$5.34M | 1.05% | 45 |
|
|
2023
Q3 | $11.1M | Hold |
41,261
| – | – | 2.05% | 19 |
|
|
2023
Q2 | $9.16M | Buy |
41,261
+10,950
| +36% | +$2.54M | 1.65% | 32 |
|
|
2023
Q1 | $7.33M | Buy |
30,311
+50
| +0.2% | +$12.3K | 1.37% | 41 |
|
|
2022
Q4 | $7.95M | Sell |
30,261
-10,650
| -26% | -$2.85M | 1.47% | 35 |
|
|
2022
Q3 | $9.22M | Buy |
40,911
+75
| +0.2% | +$18.2K | 1.96% | 21 |
|
|
2022
Q2 | $9.94M | Sell |
40,836
-4,300
| -10% | -$1.05M | 1.99% | 23 |
|
|
2022
Q1 | $10.9M | Sell |
45,136
-184
| -0.4% | -$42.3K | 1.97% | 21 |
|
|
2021
Q4 | $10.2M | Sell |
45,320
-14,550
| -24% | -$3.07M | 1.92% | 26 |
|
|
2021
Q3 | $12.7M | Hold |
59,870
| – | – | 2.54% | 9 |
|
|
2021
Q2 | $14.6M | Sell |
59,870
-11,000
| -16% | -$2.71M | 2.85% | 7 |
|
|
2021
Q1 | $17.6M | Sell |
70,870
-4,500
| -6% | -$1.07M | 2.8% | 6 |
|
|
2020
Q4 | $17.3M | Buy |
75,370
+18,100
| +32% | +$4.17M | 2.9% | 6 |
|
|
2020
Q3 | $14.6M | Sell |
57,270
-3,380
| -6% | -$837K | 2.91% | 6 |
|
|
2020
Q2 | $14.3M | Sell |
60,650
-500
| -0.8% | -$114K | 2.78% | 9 |
|
|
2020
Q1 | $12.4M | Hold |
61,150
| – | – | 2.82% | 8 |
|
|
2019
Q4 | $14.7M | Sell |
61,150
-3,500
| -5% | -$772K | 2.33% | 15 |
|
|
2019
Q3 | $12.5M | Buy |
64,650
+10,200
| +19% | +$1.96M | 1.99% | 21 |
|
|
2019
Q2 | $10M | Sell |
54,450
-11,500
| -17% | -$2.06M | 1.6% | 30 |
|
|
2019
Q1 | $12.5M | Sell |
65,950
-6,300
| -9% | -$1.2M | 2.01% | 23 |
|
|
2018
Q4 | $14.1M | Sell |
72,250
-5,250
| -7% | -$1.02M | 2.28% | 15 |
|
|
2018
Q3 | $16.1M | Buy |
77,500
+20,900
| +37% | +$4.12M | 2.08% | 19 |
|
|
2018
Q2 | $10.4M | Sell |
56,600
-550
| -1% | -$97.3K | 1.41% | 38 |
|
|
2018
Q1 | $9.74M | Buy |
57,150
+200
| +0.4% | +$36.7K | 1.32% | 39 |
|
|
2017
Q4 | $9.9M | Buy |
56,950
+3,750
| +7% | +$664K | 1.38% | 35 |
|
|
2017
Q3 | $9.92M | Buy |
53,200
+13,800
| +35% | +$2.45M | 1.43% | 37 |
|
|
2017
Q2 | $6.79M | Buy |
+39,400
| New | +$6.41M | 1.03% | 45 |
|
Other funds holding AMGN
VCM
VPM
SKBA Capital Management's AMGN Position: Q1 2026 in Review
SKBA Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 32,360 shares worth $11.4M. The position accounts for 1.56% of the portfolio, ranked #33.
SKBA Capital Management first reported a position in AMGN in Q2 2017 and has held it in 36 quarters since. The position peaked at $17.6M in Q1 2021. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- SKBA Capital Management held 32,360 shares of Amgen worth $11.4M as of Q1 2026.
- SKBA Capital Management left its Amgen share count unchanged in Q1 2026.
- Amgen made up 1.56% of SKBA Capital Management's portfolio in Q1 2026, its #33 holding.
- SKBA Capital Management first reported a position in Amgen in Q2 2017 and has held it in 36 quarters since.
- SKBA Capital Management's Amgen position peaked at $17.6M in Q1 2021.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on SKBA Capital Management's 13F filing for Q1 2026, filed 13 May 2026.